[Psychopharmacological therapy. 2. Neuroleptic agents].
D055598:Chemical Phenomena; D002621:Chemistry; D003006:Clopenthixol / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008961:Models, Structural; D010640:Phenothiazines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014970:Xanthines / Q000627:therapeutic use
D010640:Phenothiazines; D010879:Piperazines; D013843:Thiazines; D014149:Tranquilizing Agents; D014970:Xanthines; D000431:Ethanol; D012110:Reserpine; D003006:Clopenthixol; D006220:Haloperidol; D005476:Fluphenazine
Psychopharmaka-Therapie. 2. Neuroleptika.